Summary

Blood Collection Market Growth & Trends

The global blood collection market size is estimated to reach USD 6.71 billion by 2030, expanding at a CAGR of 8.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising incidence of infectious and non-communicable diseases is a major factor anticipated to propel the market growth during the forecast period. Moreover, the global burden of chronic diseases is rising rapidly. Cardiovascular disease (CVD) accounts for nearly half of all chronic disease deaths. According to the American Heart Association, the incidence of CVD in the U.S. is estimated to rise from 36.9 % (2010) to 38.7 % (2020) and 40.5% by 2030.The COVID-19 pandemic had a significant impact on the market, encompassing both direct and indirect effects. Initially, the consumption of blood collection devices for conventional diseases was reduced due to the disruption caused by the pandemic and the strain on healthcare resources.

However, as it became apparent that other diseases could be life-threatening risks for individuals infected with COVID-19, there was an increased emphasis on routine checks for blood-related diseases. This led to a temporary surge in sales in the market, which eventually led the market gradually return to its projected growth rate in 2022.The growing rate of novel product launches and investments is anticipated to fuel market growth during the forecast period. For instance, in May 2022, Terumo Blood and Cell Technologies announced the opening of its new production plant in Colorado. The plant will cater to customers in the source plasma collections by providing single-use collection kits for the newly FDA-approved Rika Plasma Donation System. This will ensure a reliable supply of collection sets specifically designed for the Rika system.

Blood Collection Market Report Highlights

• The venous blood collection segment held the highest revenue share in 2024 owing to an increase in demand for detection and diagnosis medical equipment

• The diagnostics application segment held the largest revenue share in 2024 due to the high geriatric population and the prevalence of infectious & non-communicable diseases

• In 2024, the manual collectionmethod segment accounted for the largest market share in terms of revenue owing to the wide usage of this method in hospitals, individual clinical laboratories, and pathology laboratories

• However, growing demand for safe & secure procedures and the adoption of enhanced blood collection products are driving the growth of the automated collection method segment

• In 2024, the hospitals segment accounted for the largest share due to an upsurge in the incidence of trauma & accidental cases along with a highvolume of surgical procedures

• North America held the largest revenue share in 2024, which can be attributed to the presence of a highly developed healthcare infrastructure and advanced blood collection products

• In February 2024, Tasso, Inc. announced the launch of Tasso Care for Prescreening, an advanced, end-to-end service solution crafted to elevate the effectiveness of prescreening programs. Building on Tasso's established Tasso Care services platform, this new offering leverages the company’s deep expertise in remote blood collection and analysis, streamlining and enhancing clinical trial recruitment efforts.

ページTOPに戻る

Table of Contents

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation and Scope
1.2. Market Definitions
1.2.1. Information Analysis
1.2.2. Market Formulation & Data Visualization
1.2.3. Data Validation & Publishing
1.3. Research Assumptions
1.4. Information Procurement
1.4.1. Primary Research
1.5. Information or Data Analysis
1.6. Market Formulation & Validation
1.7. Market Model
1.8. Global Market: CAGR Calculation
1.9. Objective
1.9.1. Objective 1
1.9.2. Objective2
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.1.1. Parent Market Outlook
3.1.2. Related/Ancillary Market Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.1.1. Rising incidences of infectious and non-communicable diseases
3.2.1.2. Rising number of accidental and trauma cases
3.2.1.3. Escalating number of surgical procedures
3.2.2. Market Restraint Analysis
3.2.2.1. Risks associated with blood transfusions
3.3. Industry Analysis Tools
3.3.1. Porter’s Five Forces Analysis
3.3.2. PESTEL Analysis
3.3.3. COVID-19 Impact Analysis
Chapter 4. Collection Site Business Analysis
4.1. Blood Collection Market: Collection Site Dashboard
4.2. Blood Collection Market: Collection Site Movement Analysis
4.3. Blood Collection Market by Collection Site, Revenue
4.4. Venous
4.4.1. Venous Market, 2018 - 2030 (USD Million)
4.4.2. Needles And Syringes
4.4.2.1. Needles And Syringes Market, 2018 - 2030 (USD Million)
4.4.2.2. Double-Ended Needles
4.4.2.2.1. Double-Ended Needles Market, 2018 - 2030 (USD Million)
4.4.2.3. Winged Blood Collection Sets
4.4.2.3.1. Winged Blood Collection Sets Market, 2018 - 2030 (USD Million)
4.4.2.4. Standard Hypodermic Needles
4.4.2.4.1. Standard Hypodermic Needles Market, 2018 - 2030 (USD Million)
4.4.2.5. Other Blood Collection Needles
4.4.2.5.1. Other Blood Collection Needles Market, 2018 - 2030 (USD Million)
4.4.3. Blood collection Tubes
4.4.3.1. Blood collection Tubes Market, 2018 - 2030 (USD Million)
4.4.3.2. Serum-separating Tubes
4.4.3.2.1. Serum-separating Tubes Market, 2018 - 2030 (USD Million)
4.4.3.3. EDTA Tubes
4.4.3.3.1. EDTA Tubes Market, 2018 - 2030 (USD Million)
4.4.3.4. Heparin Tubes
4.4.3.4.1. Heparin Tubes Market, 2018 - 2030 (USD Million)
4.4.3.5. Plasma-separating Tubes
4.4.3.5.1. Plasma-separating Tubes Market, 2018 - 2030 (USD Million)
4.4.4. Blood Bags
4.4.4.1. Blood Bags Market, 2018 - 2030 (USD Million)
4.4.5. Other Blood Collection Sites
4.4.5.1. Other Blood Collection Sites Market, 2018 - 2030 (USD Million)
4.5. Capillary
4.5.1. Capillary Market, 2018 - 2030 (USD Million)
4.5.2. Lancets
4.5.2.1. Lancets Market, 2018 - 2030 (USD Million)
4.5.3. Micro-Container Tubes
4.5.3.1. Micro-Container Tubes Market, 2018 - 2030 (USD Million)
4.5.4. Micro-Hematocrit Tubes
4.5.4.1. Micro-Hematocrit Tubes Market, 2018 - 2030 (USD Million)
4.5.5. Warming Devices
4.5.5.1. Warming Devices Market, 2018 - 2030 (USD Million)
4.5.6. Others
4.5.6.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Application Method Business Analysis
5.1. Blood Collection Market: Application Dashboard
5.2. Blood Collection Market: Application Movement Analysis
5.3. Blood Collection Market by Application, Revenue
5.4. Diagnostics
5.4.1. Diagnostics Market, 2018 - 2030 (USD Million)
5.5. Treatment
5.5.1. Treatment Market, 2018 - 2030 (USD Million)
Chapter 6. Method Business Analysis
6.1. Blood Collection Market: Method Movement Analysis
6.2. Manual Blood Collection
6.2.1. Manual Blood Collection Market, 2018 - 2030 (USD Million)
6.3. Automated Blood Collection
6.3.1. Automated Blood Collection Market, 2018 - 2030 (USD Million)
Chapter 7. End Use Business Analysis
7.1. Blood Collection Market: End Use Dashboard
7.2. Blood Collection Market: End Use Movement Analysis
7.3. Blood Collection Market by End Use, Revenue
7.4. Hospitals
7.4.1. Hospitals Market, 2018 - 2030 (USD Million)
7.5. Diagnostics Centers
7.5.1. Diagnostics Centers Market, 2018 - 2030 (USD Million)
7.6. Blood Banks
7.6.1. Blood Banks Market, 2018 - 2030 (USD Million)
7.7. Emergency Departments
7.7.1. Emergency Departments Market, 2018 - 2030 (USD Million)
7.8. Others
7.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 8. Regional Business Analysis
8.1. Blood Collection Market Share By Region, 2024 & 2030
8.2. North America
8.2.1. North America Blood Collection Market, 2018 - 2030 (USD Million)
8.2.2. U.S.
8.2.2.1. Key Country Dynamics
8.2.2.2. Competitive Scenario
8.2.2.3. Regulatory Framework
8.2.2.4. U.S. Blood Collection Market, 2018 - 2030 (USD Million)
8.2.3. Canada
8.2.3.1. Key Country Dynamics
8.2.3.2. Competitive Scenario
8.2.3.3. Regulatory Framework
8.2.3.4. Canada Blood Collection Market, 2018 - 2030 (USD Million)
8.2.4. Mexico
8.2.4.1. Key Country Dynamics
8.2.4.2. Competitive Scenario
8.2.4.3. Regulatory Framework
8.2.4.4. Mexico Blood Collection Market, 2018 - 2030 (USD Million)
8.3. Europe
8.3.1. Europe Blood Collection Market, 2018 - 2030 (USD Million)
8.3.2. UK
8.3.2.1. Key Country Dynamics
8.3.2.2. Competitive Scenario
8.3.2.3. Regulatory Framework
8.3.2.4. UK Blood Collection Market, 2018 - 2030 (USD Million)
8.3.3. Germany
8.3.3.1. Key Country Dynamics
8.3.3.2. Competitive Scenario
8.3.3.3. Regulatory Framework
8.3.3.4. Germany Blood Collection Market, 2018 - 2030 (USD Million)
8.3.4. France
8.3.4.1. Key Country Dynamics
8.3.4.2. Competitive Scenario
8.3.4.3. Regulatory Framework
8.3.4.4. France Blood Collection Market, 2018 - 2030 (USD Million)
8.3.5. Italy
8.3.5.1. Key Country Dynamics
8.3.5.2. Competitive Scenario
8.3.5.3. Regulatory Framework
8.3.5.4. Italy Blood Collection Market, 2018 - 2030 (USD Million)
8.3.6. Spain
8.3.6.1. Key Country Dynamics
8.3.6.2. Competitive Scenario
8.3.6.3. Regulatory Framework
8.3.6.4. Spain Blood Collection Market, 2018 - 2030 (USD Million)
8.3.7. Sweden
8.3.7.1. Key Country Dynamics
8.3.7.2. Competitive Scenario
8.3.7.3. Regulatory Framework
8.3.7.4. Sweden Blood Collection Market, 2018 - 2030 (USD Million)
8.3.8. Norway
8.3.8.1. Key Country Dynamics
8.3.8.2. Competitive Scenario
8.3.8.3. Regulatory Framework
8.3.8.4. Norway Blood Collection Market, 2018 - 2030 (USD Million)
8.3.9. Denmark
8.3.9.1. Key Country Dynamics
8.3.9.2. Competitive Scenario
8.3.9.3. Regulatory Framework
8.3.9.4. Denmark Blood Collection Market, 2018 - 2030 (USD Million)
8.3.10. Russia
8.3.10.1. Key Country Dynamics
8.3.10.2. Competitive Scenario
8.3.10.3. Regulatory Framework
8.3.10.4. Russia Blood Collection Market, 2018 - 2030 (USD Million)
8.4. Asia Pacific
8.4.1. Asia Pacific Blood Collection Market, 2018 - 2030 (USD Million)
8.4.2. China
8.4.2.1. Key Country Dynamics
8.4.2.2. Competitive Scenario
8.4.2.3. Regulatory Framework
8.4.2.4. China Blood Collection Market, 2018 - 2030 (USD Million)
8.4.3. India
8.4.3.1. Key Country Dynamics
8.4.3.2. Competitive Scenario
8.4.3.3. Regulatory Framework
8.4.3.4. India Blood Collection Market, 2018 - 2030 (USD Million)
8.4.4. Japan
8.4.4.1. Key Country Dynamics
8.4.4.2. Competitive Scenario
8.4.4.3. Regulatory Framework
8.4.4.4. Japan Blood Collection Market, 2018 - 2030 (USD Million)
8.4.5. Thailand
8.4.5.1. Key Country Dynamics
8.4.5.2. Competitive Scenario
8.4.5.3. Regulatory Framework
8.4.5.4. Thailand Blood Collection Market, 2018 - 2030 (USD Million)
8.4.6. South Korea
8.4.6.1. Key Country Dynamics
8.4.6.2. Competitive Scenario
8.4.6.3. Regulatory Framework
8.4.6.4. South Korea Blood Collection Market, 2018 - 2030 (USD Million)
8.4.7. Singapore
8.4.7.1. Key Country Dynamics
8.4.7.2. Competitive Scenario
8.4.7.3. Regulatory Framework
8.4.7.4. Singapore Blood Collection Market, 2018 - 2030 (USD Million)
8.5. Latin America
8.5.1. Latin America Blood Collection Market, 2018 - 2030 (USD Million)
8.5.2. Brazil
8.5.2.1. Key Country Dynamics
8.5.2.2. Competitive Scenario
8.5.2.3. Regulatory Framework
8.5.2.4. Brazil Blood Collection Market, 2018 - 2030 (USD Million)
8.5.3. Argentina
8.5.3.1. Key Country Dynamics
8.5.3.2. Competitive Scenario
8.5.3.3. Regulatory Framework
8.5.3.4. Argentina Blood Collection Market, 2018 - 2030 (USD Million)
8.6. MEA
8.6.1. MEA Blood Collection Market, 2018 - 2030 (USD Million)
8.6.2. Saudi Arabia
8.6.2.1. Key Country Dynamics
8.6.2.2. Competitive Scenario
8.6.2.3. Regulatory Framework
8.6.2.4. Saudi Arabia Blood Collection Market, 2018 - 2030 (USD Million)
8.6.3. South Africa
8.6.3.1. Key Country Dynamics
8.6.3.2. Competitive Scenario
8.6.3.3. Regulatory Framework
8.6.3.4. South Africa Blood Collection Market, 2018 - 2030 (USD Million)
8.6.4. UAE
8.6.4.1. Key Country Dynamics
8.6.4.2. Competitive Scenario
8.6.4.3. Regulatory Framework
8.6.4.4. UAE Blood Collection Market, 2018 - 2030 (USD Million)
8.6.5. Kuwait
8.6.5.1. Key Country Dynamics
8.6.5.2. Competitive Scenario
8.6.5.3. Regulatory Framework
8.6.5.4. Kuwait Blood Collection Market, 2018 - 2030 (USD Million)
Chapter 9. Competitive Landscape
9.1. Company Categorization
9.2. Strategy Mapping
9.3. Company Market Share Analysis, 2024
9.4. Company Profiles/Listing
9.4.1. Abbott
9.4.1.1. Overview
9.4.1.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.1.3. Collection Site Benchmarking
9.4.1.4. Strategic Initiatives
9.4.2. NIPRO Medical Corporation
9.4.2.1. Overview
9.4.2.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.2.3. Collection Site Benchmarking
9.4.2.4. Strategic Initiatives
9.4.3. BD (Becton, Dickinson and Company)
9.4.3.1. Overview
9.4.3.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.3.3. Collection Site Benchmarking
9.4.3.4. Strategic Initiatives
9.4.4. Terumo Corporation
9.4.4.1. Overview
9.4.4.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.4.3. Collection Site Benchmarking
9.4.4.4. Strategic Initiatives
9.4.5. Medtronic
9.4.5.1. Overview
9.4.5.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.5.3. Collection Site Benchmarking
9.4.5.4. Strategic Initiatives
9.4.6. QIAGEN
9.4.6.1. Overview
9.4.6.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.6.3. Collection Site Benchmarking
9.4.6.4. Strategic Initiatives
9.4.7. FL MEDICAL s.r.l.
9.4.7.1. Overview
9.4.7.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.7.3. Collection Site Benchmarking
9.4.7.4. Strategic Initiatives
9.4.8. Greiner AG
9.4.8.1. Overview
9.4.8.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.8.3. Collection Site Benchmarking
9.4.8.4. Strategic Initiatives
9.4.9. Haemonetics Corporation
9.4.9.1. Overview
9.4.9.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.9.3. Collection Site Benchmarking
9.4.9.4. Strategic Initiatives
9.4.10. Sarstedt AG & Co.
9.4.10.1. Overview
9.4.10.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.10.3. Collection Site Benchmarking
9.4.10.4. Strategic Initiatives
9.4.11. Centogene N.V.
9.4.11.1. Overview
9.4.11.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.11.3. Collection Site Benchmarking
9.4.11.4. Strategic Initiatives
9.4.12. SEKISUI CHEMICAL CO., LTD.
9.4.12.1. Overview
9.4.12.2. Financial Performance (Net Revenue/Sales/EBITDA/Gross Profit)
9.4.12.3. Collection Site Benchmarking
9.4.12.4. Strategic Initiatives